Atara Biotherapeutics (ATRA) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to -$10.2 million.
- Atara Biotherapeutics' Other Gross PP&E Adjustments rose 6112.54% to -$10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.2 million, marking a year-over-year increase of 6112.54%. This contributed to the annual value of -$27.0 million for FY2024, which is 4518.0% up from last year.
- Per Atara Biotherapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$10.2 million for Q3 2025, which was up 6112.54% from -$10.5 million recorded in Q2 2025.
- Over the past 5 years, Atara Biotherapeutics' Other Gross PP&E Adjustments peaked at $427000.0 during Q1 2022, and registered a low of -$68.5 million during Q4 2022.
- Over the past 4 years, Atara Biotherapeutics' median Other Gross PP&E Adjustments value was -$39.6 million (recorded in 2023), while the average stood at -$35.7 million.
- As far as peak fluctuations go, Atara Biotherapeutics' Other Gross PP&E Adjustments plummeted by 1087985.95% in 2023, and later surged by 6415.89% in 2025.
- Atara Biotherapeutics' Other Gross PP&E Adjustments (Quarter) stood at -$68.5 million in 2022, then grew by 28.11% to -$49.2 million in 2023, then surged by 45.18% to -$27.0 million in 2024, then skyrocketed by 62.38% to -$10.2 million in 2025.
- Its Other Gross PP&E Adjustments was -$10.2 million in Q3 2025, compared to -$10.5 million in Q2 2025 and -$48.8 million in Q1 2025.